Russian firm gets approval for drug said to block coronavirus replication
10 Jul 2020
Russia has approved a new antiviral drug, Coronavir, to treat COVID-19 patients, its developer R-Pharm said on Wednesday, as Russia's tally of infections hit 700,000. It said a clinical...